Jenburkt Pharmaceuticals share news, announcements and annual reports
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹853.60.
2 Nov: open ₹863.10, high ₹866.90, low ₹863.00
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹382 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.64
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.39
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.39%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53698.1% delivered
Jenburkt Pharmaceuticals share news and announcements
653 announcements, routine notices left out, newest first. Page 7 of 14.
Jun 2020
25 Jun · Disclosure Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018.
19 Jun · Board meeting
Meeting on 30 Jun 2020: audited results5 Jun · Disclosure Under Regulation 30 Of SEBI-LODR
May 2020
29 May · Compliance With Reference To Regulation 7 (3) Of SEBI -LODR
23 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....20 May · Regulation 40(9) Of SEBI(Listing Obligation And Disclosure Requirements) Regulation 2015.
1 May · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Mar 2020
17 Mar · Board meeting
Meeting on 28 Mar 20202 Mar · Board meeting
Meeting on 6 Mar 2020: interim dividend
Feb 2020
7 Feb · Unaudited Quarterly Result For The Period From 1St October To 31St December 2019.
Jan 2020
27 Jan · Board meeting
Meeting on 7 Feb 2020: quarterly results7 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2019
7 Nov · Compliance Under Regulation 23(9)
Oct 2019
30 Oct · Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015.
23 Oct · Board meeting
Meeting on 5 Nov 2019: audited results10 Oct · Compliance Certificate For The Period Ended 30Th September, 2019.
10 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....9 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 0
Sep 2019
28 Sep · Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015
Aug 2019
1 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Jul 2019
31 Jul · Meeting
31 Jul · Meeting
16 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....8 Jul · Board meeting
Meeting on 30 Jul 2019: quarterly results5 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Jun 2019
25 Jun · Reg. 34 (1) Annual Report
11 Jun · Compliance Under Regulation 23(9) Of SEBI - LODR
May 2019
28 May · Meeting
Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended a Final Dividend of Rs. 10.20 (102%) ....28 May · Board meeting
17 May · Board meeting
Meeting on 28 May 2019: audited results and final dividend